#HogiMedical

The tender offer period by TCG2509 Co., Ltd. for shares of Hogi Medical Co., Ltd. has been extended to 40 business days from February 5, 2026, and the settlement start date has also been postponed to March 2, 2026.

TCG2509 Co., Ltd. has extended the tender offer period for shares of Hogi Medical Co., Ltd. from February 5, 2026, to 40 business days (until February 20, 2026) and changed the settlement start date to March 2, 2026.

For the third quarter of the fiscal year ending March 2026, net sales amounted to 28,719 million yen (4.3% decrease year-over-year), operating income was 2,088 million yen (38.7% decrease year-over-year), and quarterly net income attributable to owners of the parent was 1,438 million yen (47.4% decrease year-over-year).

For the cumulative third quarter of the fiscal year ending March 2026, net sales were JPY 28.71 billion (95.7% YoY), operating income was JPY 2.08 billion (61.3% YoY), and net income attributable to owners of parent was JPY 1.43 billion (52.6% YoY), all showing declines.

In relation to the tender offer by TCG2509 Co., Ltd. for Hogi Medical Co., Ltd., the number of shares owned by GMO was corrected from 2,237,900 shares (10.38%) to 2,256,100 shares (10.46%), and on January 6, 2026, an amendment to the subscription agreement was executed.